The EHA Annual Congress provides a forum for presenting original unpublished data and sharing ideas for haematological innovation as well as disseminating evidence-based knowledge of primary clinical relevance.
Haematologists and affiliated professionals attending the EHA Congress will be able to:
-
Enhance their knowledge of evidence-based approaches on diagnosis and treatment for hematologic diseases.
-
Access the latest results on clinical and translational research in hematologic disorders.
-
Be updated on emerging innovative techniques, diagnostic tools and risk-assessment strategies in haematology and its subspecialties.
-
Communicate, collaborate and network with representatives of a large international audience – medical professionals, national haematology societies, patient groups, medical industry and the media.
